Andera Partners is a Paris-based private equity and asset management firm specializing in growth capital, mezzanine financing, infrastructure, and life sciences investments. Founded in 2001, the firm manages approximately €6 billion across more than 360 portfolio companies in Europe and the United States.
41% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $87.8M (across 52 rounds with reported amounts).
Portfolio
70
Fund Size
—
Top Stage
Series B
Last 12 Mo
10
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
99 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Cyllene | Series C | — | Jul 2026 |
 Exciva | Series B | — | Jan 2026 |
 Alveus Therapeutics | Series A | $160M | Jan 2026 |
 Spiro Medical | Series A | $67M | Jan 2026 |
 TargED Biopharmaceuticals B.V. | Series A | — | Dec 2025 |
 Artios Pharma | Series D | $115M | Nov 2025 |
| AArtios | Series D | $115M | Nov 2025 |
 Adcytherix | Series A | — | Oct 2025 |
 Tubulis | Series C | — | Oct 2025 |
| TTubulis GmbH | Series C | — | Oct 2025 |
 EG 427 | Series B | — | Feb 2025 |
| Exciva | Series B | $59M | Jan 2025 |
 Bioptimus | Series A | $41M | Jan 2025 |
 Fire1 | Unknown | $120M | Jan 2025 |
 Evommune | Series C | $115M | Oct 2024 |
| EEVOMMUNE INC. | Series C | $115M | Oct 2024 |
 Inventiva | Unknown | — | Oct 2024 |
 TriCares | Series D | $50M | Jul 2024 |
 Scirhom | Series A | — | Jul 2024 |
| GGrey Wolf Therapeutics | Series B | $50M | May 2024 |
 Greywolf Therapeutics | Series B | $50M | May 2024 |
| MMedical Microinstruments | Series C | $110M | Feb 2024 |
| TriCares | Series D | $50M | Jan 2024 |
| KKestra Medical | Unknown | $196M | Jan 2024 |
| MMedical Microinstruments | Series C | $110M | Jan 2024 |
Page 1 of 4
Top Co-Investors
EQT Life Sciences19 shared
RA Capital Management17 shared
Sofinnova Partners16 shared
M Ventures15 shared
Pfizer Ventures15 shared
Omega Funds15 shared
SV Health Investors11 shared
The Invus Group, LLC11 shared
Kurma Partners10 shared
Gimv10 shared
IP Group plc10 shared
Bpifrance9 shared
Arix Bioscience9 shared
Wellington Management8 shared
Cormorant Asset Management8 shared
Sectoral Asset Management7 shared
Schroders Capital7 shared
Avidity Partners7 shared
Deep Track Capital6 shared
Fund+6 shared
Last updated: 9 September 2026